KIAA1468 inhibitors are a class of chemical compounds designed to target and inhibit the function of the KIAA1468 protein, a relatively uncharacterized protein encoded by the KIAA1468 gene. While the exact biological role of KIAA1468 is still under investigation, it is believed to be involved in intracellular signaling pathways, cellular organization, or potentially in protein-protein interactions that regulate various aspects of cell biology. Proteins like KIAA1468, which have yet to be fully characterized, often provide opportunities for exploring new cellular functions and mechanisms. Inhibiting KIAA1468 allows researchers to probe its specific contributions to cellular processes and to identify its molecular partners and the pathways it influences.
The mechanism by which KIAA1468 inhibitors work likely involves interfering with key functional domains of the protein, such as those responsible for binding to other proteins or cellular components. These inhibitors may bind to active sites or allosteric regions of the protein, leading to changes in its structure or function, which ultimately block its activity. Structurally, KIAA1468 inhibitors are typically designed to mimic natural substrates or binding partners of the protein, enabling precise interaction with KIAA1468 to selectively inhibit its function. By studying KIAA1468 inhibitors, researchers can gain insights into how this protein affects cellular processes like signal transduction, structural organization, or potentially its role in specific signaling pathways. This research not only sheds light on the functions of KIAA1468 but also contributes to a broader understanding of the complex regulatory networks within cells and how individual proteins influence these networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor, affecting multiple signaling pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, impacting protein degradation and NF-kB pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, affecting cell proliferation and apoptosis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, influencing cell growth and protein synthesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, specifically blocking MEK1, thus affecting cell growth and apoptosis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, influencing inflammatory responses and cell stress pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, involved in stress responses and apoptosis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, used clinically for certain types of cancer. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of SERCA, affecting calcium homeostasis. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A broad-spectrum caspase inhibitor, impacting apoptosis pathways. | ||||||